Evidence map›Paper›PMID 32796958›Full record

ArticleOncogene2020

LINC00467 is up-regulated by TDG-mediated acetylation in non-small cell lung cancer and promotes tumor progression.

Yuxing Zhu, Jingjing Li, Hao Bo, Dong He, Mengqing Xiao, Liang Xiang, Lian Gong, Yi Hu, Yeyu Zhang, Yaxin Cheng and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. The hidden players: LncRNA-Encoded micropeptides in cancer hallmarks.Cellular and molecular life sciences : CMLS · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Epigenetic Factors and ncRNAs in Testicular Cancer.International journal of molecular sciences · 2023
    Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. LINC00467: an oncogenic long noncoding RNA.Cancer cell international · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Yuxing Zhu *Department of Oncology, Third Xiangya Hospital of Central South University, Changsha, 410013, China.
Jingjing Li *Department of Oncology, Third Xiangya Hospital of Central South University, Changsha, 410013, China.
Hao Bo *Clinical Research Center for Reproduction and Genetics in Hunan Province, Reproductive and Genetic Hospital of CITIC-Xiangya, Changsha, 410078, China.
Dong HeDepartment of Respiratory, The Second People's Hospital of Hunan Province, Chansha, 410007, China.
Mengqing XiaoDepartment of Oncology, Third Xiangya Hospital of Central South University, Changsha, 410013, China.
Liang XiangDepartment of Oncology, Third Xiangya Hospital of Central South University, Changsha, 410013, China.
Lian GongDepartment of Oncology, Third Xiangya Hospital of Central South University, Changsha, 410013, China.
Yi HuDepartment of Oncology, Third Xiangya Hospital of Central South University, Changsha, 410013, China.
Yeyu ZhangDepartment of Oncology, Third Xiangya Hospital of Central South University, Changsha, 410013, China.
Yaxin ChengDepartment of Oncology, Third Xiangya Hospital of Central South University, Changsha, 410013, China.
Liping DengDepartment of Oncology, Third Xiangya Hospital of Central South University, Changsha, 410013, China.
Rongrong ZhuDepartment of Oncology, Third Xiangya Hospital of Central South University, Changsha, 410013, China.
Yanni MaDepartment of Oncology, Third Xiangya Hospital of Central South University, Changsha, 410013, China.
Ke CaoDepartment of Oncology, Third Xiangya Hospital of Central South University, Changsha, 410013, China. csucaoke@163.com.ORCID http://orcid.org/0000-0001-5392-2306
Central South University · CNSecond People Hospital of Hunan · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The long non-coding RNA (LncRNA) abnormally expresses in several cancers including non-small cell lung cancer (NSCLC). To better understand the role of key lncRNA involving cancer progress, we conduct a comprehensive data mining on LINC00467 and determine its molecular mechanisms. We identified LINC00467 was the up-regulated lncRNA that common significantly differentially expressed in NSCLC and CRC tissues from GEO database. LINC00467 highly expressed in NSCLC tissues and associated with advanced clinical stages and poor outcome. Knockdown of LINC00467 inhibited cell growth and metastasis via regulating the Akt signaling pathway. Finally, we demonstrated that TDG mediated acetylation is the key factor controlling LINC00467 expression. In conclusion, LINC00467 promotes NSCLC progression via Akt signal pathway. The identified LINC00467 may serve as a valuable diagnostic and prognostic biomarker as well as a therapeutic target for NSCLC.

Indexed as

Gene Expression Regulation, NeoplasticAcetylationAdipokinesAnimalsCarcinoma, Non-Small-Cell LungCell Line, TumorCell MovementCell ProliferationDisease Models, AnimalDisease ProgressionHeterograftsHumansKaplan-Meier EstimateLung NeoplasmsMiceModels, BiologicalAdipokinesAZGP1 protein, humanProto-Oncogene Proteins c-aktRNA, Long NoncodingZn-Alpha-2-Glycoprotein

Identifiers

PMID32796958
OpenAlexW3049350830

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.